Ghosh Anirvan
Chief Executive Officer at Unity Biotechnology, Inc.
- Sold, on record
- $183k
- Dollars the filings state
- Form 4 sales
- 26
- Latest Apr 2, 2025
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Unity Biotechnology, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Unity Biotechnology, Inc.No planJan 30, 2024 2024
Sold 1,183 shares at $1.71 ($2k)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 1.5% of holdings ($138k position)79,426 shares left1x usual sizeFiling
- 2 Form 4 sale Unity Biotechnology, Inc.No planFeb 2, 2024 +3 days
Sold 680 shares at $1.71 ($1k)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 0.9% of holdings ($136k position)78,746 shares left0.6x usual sizeFiling
- 3 Form 4 sale Unity Biotechnology, Inc.No planMay 2, 2024 +90 days
Sold 603 shares at $1.55 ($935)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 0.8% of holdings ($122k position)78,143 shares left0.5x usual sizeFiling
- 4 Form 4 sale Unity Biotechnology, Inc.No planJun 25, 2024 +54 days
Sold 1,214 shares at $1.40 ($2k)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 1.6% of holdings ($109k position)76,929 shares left1x usual sizeFiling
- 5 Form 4 sale Unity Biotechnology, Inc.No planAug 2, 2024 +38 days
Sold 604 shares at $1.53 ($924)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 0.8% of holdings ($118k position)76,325 shares left0.5x usual sizeFiling
- 6 Form 4 sale Unity Biotechnology, Inc.No planNov 4, 2024 +94 days
Sold 432 shares at $1.29 ($557)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 0.6% of holdings ($98k position)75,893 shares left0.4x usual sizeFiling
- 7 Form 4 sale Unity Biotechnology, Inc.No planFeb 4, 2025 +92 days
Sold 642 shares at $2.23 ($1k)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 0.8% of holdings ($169k position)75,251 shares left0.6x usual sizeFiling
- 8 Form 4 sale Unity Biotechnology, Inc.UnusualApr 2, 2025 +57 days
Sold 96,797 shares at $1.03 ($100k)
Ghosh Anirvan, Chief Executive Officer
No 10b5-1 planSold 38.7% of holdings ($258k position)153,454 shares left113.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (33)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Apr 3, 2025 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 96,797 | $100k | 38.7% | Unusual | SEC |
| Feb 4, 2025 | Feb 5, 2025 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 642 | $1k | 0.8% | No plan | SEC |
| Nov 4, 2024 | Nov 6, 2024 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 432 | $557 | 0.6% | No plan | SEC |
| Aug 2, 2024 | Aug 6, 2024 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 604 | $924 | 0.8% | No plan | SEC |
| Jun 25, 2024 | Jun 26, 2024 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,214 | $2k | 1.6% | No plan | SEC |
| May 2, 2024 | May 3, 2024 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 603 | $935 | 0.8% | No plan | SEC |
| Feb 2, 2024 | Feb 5, 2024 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 680 | $1k | 0.9% | No plan | SEC |
| Jan 30, 2024 | Jan 31, 2024 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,183 | $2k | 1.5% | No plan | SEC |
| Nov 2, 2023 | Nov 3, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 589 | $1k | 0.7% | No plan | SEC |
| Oct 30, 2023 | Oct 31, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,024 | $2k | 1.2% | No plan | SEC |
| Sep 15, 2023 | Sep 15, 2023 | Unity Biotechnology, Inc. | Officer, Director | Form 144 notice | 1,246 | $3k | Notice | SEC | |
| Sep 14, 2023 | Sep 15, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,246 | $3k | 1.5% | No plan | SEC |
| Aug 3, 2023 | Aug 3, 2023 | Unity Biotechnology, Inc. | Officer, Director | Form 144 notice | 581 | $2k | Notice | SEC | |
| Aug 2, 2023 | Aug 3, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 581 | $2k | 0.7% | No plan | SEC |
| Aug 1, 2023 | Aug 1, 2023 | Unity Biotechnology, Inc. | Officer, Director | Form 144 notice | 1,020 | $3k | Notice | SEC | |
| Jul 31, 2023 | Aug 1, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,020 | $3k | 1.2% | No plan | SEC |
| Jun 27, 2023 | Jun 27, 2023 | Unity Biotechnology, Inc. | Officer | Form 144 notice | 1,177 | $4k | Notice | SEC | |
| Jun 26, 2023 | Jun 27, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,177 | $4k | 1.4% | No plan | SEC |
| Jun 14, 2023 | Jun 15, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,212 | $4k | 1.4% | No plan | SEC |
| Jun 14, 2023 | Jun 14, 2023 | Unity Biotechnology, Inc. | Officer | Form 144 notice | 1,212 | $4k | Notice | SEC | |
| May 3, 2023 | May 3, 2023 | Unity Biotechnology, Inc. | Officer | Form 144 notice | 588 | $1k | Notice | SEC | |
| May 2, 2023 | May 3, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 588 | $1k | 0.7% | No plan | SEC |
| May 2, 2023 | May 2, 2023 | Unity Biotechnology, Inc. | Officer, Director | Form 144 notice | 1,020 | $2k | Notice | SEC | |
| May 1, 2023 | May 2, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,020 | $2k | 92.1% | Unusual | SEC |
| Mar 31, 2023 | Apr 3, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,959 | $3k | 2.2% | No plan | SEC |
| Mar 14, 2023 | Mar 15, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,210 | $5k | 1.3% | Plan not stated | SEC |
| Feb 2, 2023 | Feb 3, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 2,573 | $12k | 2.7% | Plan not stated | SEC |
| Jan 30, 2023 | Jan 31, 2023 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,140 | $5k | 1.2% | Plan not stated | SEC |
| Dec 14, 2022 | Dec 15, 2022 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,274 | $4k | 1.3% | Plan not stated | SEC |
| Nov 3, 2022 | Nov 4, 2022 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 1,099 | $3k | 1.1% | Plan not stated | SEC |
| Sep 14, 2022 | Sep 15, 2022 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 13,706 | $7k | 1.4% | Plan not stated | SEC |
| Aug 1, 2022 | Aug 2, 2022 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 10,446 | $7k | 1.0% | Plan not stated | SEC |
| Jun 27, 2022 | Jun 28, 2022 | Unity Biotechnology, Inc. | Chief Executive Officer | Form 4 sale | 12,149 | $7k | 1.2% | Plan not stated | SEC |